Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity
Ulf Schulze‐Topphoff(University of California, San Francisco), Scott S. Zamvil(University of California, San Francisco)
Cited by 97
Related Papers
Glatiramer acetate treatment negatively regulates type I interferon signaling
|Neurology Neuroimmunology & Neuroinflammation|2015|18